New Delhi: An anti-cancer therapeutic vaccine, developed by Indian scientists, is all set to undergo clinical trials in Chennai and the US in the next few months. The vaccine, developed by scientists at the National Institute of Immunology (NII), seeks to prolong the life-span of patients with advanced stages of various kinds of cancer, including that of breast, ovarian, cervical and blood. "The first clinical trials are expected to begin at Adayar Cancer Institute in Chennai early next year," Anil Suri, Convenor of the Cancer Research Programme at the NII said. NII has also signed agreements with the National Cancer Institute in the US for undertaking clinical trials at the Sloan Kettering Memorial cancer hospital in New York. While the trial at Adayar Cancer Institute would focus on cervical cancer, the vaccine`s efficacy against ovarian cancer would be tested at Sloan Kettering, Suri said. The Adayar hospital has plans to test the vaccine on 18 patients with Stage-III cancer and their responses will be compared against another group of 18 patients receiving standard therapy for cervical cancer.
Taiwan:TransAsia Airways crashes during emergency landing
Basketball Asia Cup: Sikh players forced to remove turbans
Shiv Sena MPs `force` fasting Muslim to eat during Ramzan
Don`t take us for granted, NCP warns Congress